Financhill
Sell
30

STRR Quote, Financials, Valuation and Earnings

Last price:
$2.21
Seasonality move :
-1.34%
Day range:
$2.17 - $2.20
52-week range:
$1.72 - $5.35
Dividend yield:
0%
P/E ratio:
0.75x
P/S ratio:
0.12x
P/B ratio:
0.21x
Volume:
492.3K
Avg. volume:
36.3K
1-year change:
-51.24%
Market cap:
$7M
Revenue:
$53.4M
EPS (TTM):
-$3.58

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
STRR
Star Equity Holdings
$16.4M -$0.25 18.67% -43.28% $8.50
CTSO
CytoSorbents
$9M -$0.07 12.94% -41.38% $5.00
DCTH
Delcath Systems
$16.8M $0.03 179.13% -93.78% $23.00
EXAS
Exact Sciences
$688.6M -$0.10 10.52% -84.17% $68.83
ILMN
Illumina
$1B $0.94 -5.72% 430.2% $106.53
NTRA
Natera
$446.7M -$0.66 15.16% -106.89% $191.91
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
STRR
Star Equity Holdings
$2.17 $8.50 $7M 0.75x $0.00 0% 0.12x
CTSO
CytoSorbents
$0.87 $5.00 $54.5M -- $0.00 0% 1.38x
DCTH
Delcath Systems
$17.24 $23.00 $600.4M -- $0.00 0% 10.59x
EXAS
Exact Sciences
$56.89 $68.83 $10.7B -- $0.00 0% 3.73x
ILMN
Illumina
$79.37 $106.53 $12.6B -- $0.00 0% 2.91x
NTRA
Natera
$151.09 $191.91 $20.6B -- $0.00 0% 10.58x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
STRR
Star Equity Holdings
18.39% -0.314 40.47% 0.69x
CTSO
CytoSorbents
49.38% 1.160 22.69% 1.98x
DCTH
Delcath Systems
-- 2.997 -- 13.86x
EXAS
Exact Sciences
49.21% 0.148 28.45% 2.12x
ILMN
Illumina
45.66% 0.950 15.77% 1.34x
NTRA
Natera
6.09% 3.386 0.42% 3.58x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
STRR
Star Equity Holdings
$3.1M -$2.8M -13.58% -15.99% -22.03% $200K
CTSO
CytoSorbents
$6.2M -$3.9M -58.93% -106.57% -10.01% -$3.5M
DCTH
Delcath Systems
$16.9M $642K -37.34% -40.28% 3.25% $2.1M
EXAS
Exact Sciences
$500.5M -$89.8M -19.08% -35.57% -13.04% -$365K
ILMN
Illumina
$683M $164M -20.34% -34.38% 19.89% $201M
NTRA
Natera
$316.8M -$79.2M -15.3% -19.19% -13.1% $22.6M

Star Equity Holdings vs. Competitors

  • Which has Higher Returns STRR or CTSO?

    CytoSorbents has a net margin of -9.1% compared to Star Equity Holdings's net margin of -16.94%. Star Equity Holdings's return on equity of -15.99% beat CytoSorbents's return on equity of -106.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    STRR
    Star Equity Holdings
    24.27% -$0.52 $73.2M
    CTSO
    CytoSorbents
    71.13% -$0.02 $28.7M
  • What do Analysts Say About STRR or CTSO?

    Star Equity Holdings has a consensus price target of $8.50, signalling upside risk potential of 291.72%. On the other hand CytoSorbents has an analysts' consensus of $5.00 which suggests that it could grow by 474.71%. Given that CytoSorbents has higher upside potential than Star Equity Holdings, analysts believe CytoSorbents is more attractive than Star Equity Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    STRR
    Star Equity Holdings
    1 0 0
    CTSO
    CytoSorbents
    1 1 0
  • Is STRR or CTSO More Risky?

    Star Equity Holdings has a beta of 0.871, which suggesting that the stock is 12.92% less volatile than S&P 500. In comparison CytoSorbents has a beta of 1.171, suggesting its more volatile than the S&P 500 by 17.12%.

  • Which is a Better Dividend Stock STRR or CTSO?

    Star Equity Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoSorbents offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Star Equity Holdings pays -19.54% of its earnings as a dividend. CytoSorbents pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios STRR or CTSO?

    Star Equity Holdings quarterly revenues are $12.9M, which are larger than CytoSorbents quarterly revenues of $8.7M. Star Equity Holdings's net income of -$1.2M is higher than CytoSorbents's net income of -$1.5M. Notably, Star Equity Holdings's price-to-earnings ratio is 0.75x while CytoSorbents's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Star Equity Holdings is 0.12x versus 1.38x for CytoSorbents. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STRR
    Star Equity Holdings
    0.12x 0.75x $12.9M -$1.2M
    CTSO
    CytoSorbents
    1.38x -- $8.7M -$1.5M
  • Which has Higher Returns STRR or DCTH?

    Delcath Systems has a net margin of -9.1% compared to Star Equity Holdings's net margin of 5.4%. Star Equity Holdings's return on equity of -15.99% beat Delcath Systems's return on equity of -40.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    STRR
    Star Equity Holdings
    24.27% -$0.52 $73.2M
    DCTH
    Delcath Systems
    85.62% $0.03 $80.2M
  • What do Analysts Say About STRR or DCTH?

    Star Equity Holdings has a consensus price target of $8.50, signalling upside risk potential of 291.72%. On the other hand Delcath Systems has an analysts' consensus of $23.00 which suggests that it could grow by 34.38%. Given that Star Equity Holdings has higher upside potential than Delcath Systems, analysts believe Star Equity Holdings is more attractive than Delcath Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    STRR
    Star Equity Holdings
    1 0 0
    DCTH
    Delcath Systems
    4 0 0
  • Is STRR or DCTH More Risky?

    Star Equity Holdings has a beta of 0.871, which suggesting that the stock is 12.92% less volatile than S&P 500. In comparison Delcath Systems has a beta of 0.722, suggesting its less volatile than the S&P 500 by 27.805%.

  • Which is a Better Dividend Stock STRR or DCTH?

    Star Equity Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Star Equity Holdings pays -19.54% of its earnings as a dividend. Delcath Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios STRR or DCTH?

    Star Equity Holdings quarterly revenues are $12.9M, which are smaller than Delcath Systems quarterly revenues of $19.8M. Star Equity Holdings's net income of -$1.2M is lower than Delcath Systems's net income of $1.1M. Notably, Star Equity Holdings's price-to-earnings ratio is 0.75x while Delcath Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Star Equity Holdings is 0.12x versus 10.59x for Delcath Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STRR
    Star Equity Holdings
    0.12x 0.75x $12.9M -$1.2M
    DCTH
    Delcath Systems
    10.59x -- $19.8M $1.1M
  • Which has Higher Returns STRR or EXAS?

    Exact Sciences has a net margin of -9.1% compared to Star Equity Holdings's net margin of -14.32%. Star Equity Holdings's return on equity of -15.99% beat Exact Sciences's return on equity of -35.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    STRR
    Star Equity Holdings
    24.27% -$0.52 $73.2M
    EXAS
    Exact Sciences
    70.82% -$0.54 $4.7B
  • What do Analysts Say About STRR or EXAS?

    Star Equity Holdings has a consensus price target of $8.50, signalling upside risk potential of 291.72%. On the other hand Exact Sciences has an analysts' consensus of $68.83 which suggests that it could grow by 20.99%. Given that Star Equity Holdings has higher upside potential than Exact Sciences, analysts believe Star Equity Holdings is more attractive than Exact Sciences.

    Company Buy Ratings Hold Ratings Sell Ratings
    STRR
    Star Equity Holdings
    1 0 0
    EXAS
    Exact Sciences
    18 4 0
  • Is STRR or EXAS More Risky?

    Star Equity Holdings has a beta of 0.871, which suggesting that the stock is 12.92% less volatile than S&P 500. In comparison Exact Sciences has a beta of 0.920, suggesting its less volatile than the S&P 500 by 7.968%.

  • Which is a Better Dividend Stock STRR or EXAS?

    Star Equity Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Star Equity Holdings pays -19.54% of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios STRR or EXAS?

    Star Equity Holdings quarterly revenues are $12.9M, which are smaller than Exact Sciences quarterly revenues of $706.8M. Star Equity Holdings's net income of -$1.2M is higher than Exact Sciences's net income of -$101.2M. Notably, Star Equity Holdings's price-to-earnings ratio is 0.75x while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Star Equity Holdings is 0.12x versus 3.73x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STRR
    Star Equity Holdings
    0.12x 0.75x $12.9M -$1.2M
    EXAS
    Exact Sciences
    3.73x -- $706.8M -$101.2M
  • Which has Higher Returns STRR or ILMN?

    Illumina has a net margin of -9.1% compared to Star Equity Holdings's net margin of 12.58%. Star Equity Holdings's return on equity of -15.99% beat Illumina's return on equity of -34.38%.

    Company Gross Margin Earnings Per Share Invested Capital
    STRR
    Star Equity Holdings
    24.27% -$0.52 $73.2M
    ILMN
    Illumina
    65.61% $0.82 $4.4B
  • What do Analysts Say About STRR or ILMN?

    Star Equity Holdings has a consensus price target of $8.50, signalling upside risk potential of 291.72%. On the other hand Illumina has an analysts' consensus of $106.53 which suggests that it could grow by 34.22%. Given that Star Equity Holdings has higher upside potential than Illumina, analysts believe Star Equity Holdings is more attractive than Illumina.

    Company Buy Ratings Hold Ratings Sell Ratings
    STRR
    Star Equity Holdings
    1 0 0
    ILMN
    Illumina
    7 11 0
  • Is STRR or ILMN More Risky?

    Star Equity Holdings has a beta of 0.871, which suggesting that the stock is 12.92% less volatile than S&P 500. In comparison Illumina has a beta of 1.349, suggesting its more volatile than the S&P 500 by 34.945%.

  • Which is a Better Dividend Stock STRR or ILMN?

    Star Equity Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Star Equity Holdings pays -19.54% of its earnings as a dividend. Illumina pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios STRR or ILMN?

    Star Equity Holdings quarterly revenues are $12.9M, which are smaller than Illumina quarterly revenues of $1B. Star Equity Holdings's net income of -$1.2M is lower than Illumina's net income of $131M. Notably, Star Equity Holdings's price-to-earnings ratio is 0.75x while Illumina's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Star Equity Holdings is 0.12x versus 2.91x for Illumina. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STRR
    Star Equity Holdings
    0.12x 0.75x $12.9M -$1.2M
    ILMN
    Illumina
    2.91x -- $1B $131M
  • Which has Higher Returns STRR or NTRA?

    Natera has a net margin of -9.1% compared to Star Equity Holdings's net margin of -13.34%. Star Equity Holdings's return on equity of -15.99% beat Natera's return on equity of -19.19%.

    Company Gross Margin Earnings Per Share Invested Capital
    STRR
    Star Equity Holdings
    24.27% -$0.52 $73.2M
    NTRA
    Natera
    63.12% -$0.50 $1.3B
  • What do Analysts Say About STRR or NTRA?

    Star Equity Holdings has a consensus price target of $8.50, signalling upside risk potential of 291.72%. On the other hand Natera has an analysts' consensus of $191.91 which suggests that it could grow by 27.02%. Given that Star Equity Holdings has higher upside potential than Natera, analysts believe Star Equity Holdings is more attractive than Natera.

    Company Buy Ratings Hold Ratings Sell Ratings
    STRR
    Star Equity Holdings
    1 0 0
    NTRA
    Natera
    12 0 0
  • Is STRR or NTRA More Risky?

    Star Equity Holdings has a beta of 0.871, which suggesting that the stock is 12.92% less volatile than S&P 500. In comparison Natera has a beta of 1.794, suggesting its more volatile than the S&P 500 by 79.445%.

  • Which is a Better Dividend Stock STRR or NTRA?

    Star Equity Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Natera offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Star Equity Holdings pays -19.54% of its earnings as a dividend. Natera pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios STRR or NTRA?

    Star Equity Holdings quarterly revenues are $12.9M, which are smaller than Natera quarterly revenues of $501.8M. Star Equity Holdings's net income of -$1.2M is higher than Natera's net income of -$66.9M. Notably, Star Equity Holdings's price-to-earnings ratio is 0.75x while Natera's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Star Equity Holdings is 0.12x versus 10.58x for Natera. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STRR
    Star Equity Holdings
    0.12x 0.75x $12.9M -$1.2M
    NTRA
    Natera
    10.58x -- $501.8M -$66.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is GlobalFoundries On The Verge Of A Breakout?
Is GlobalFoundries On The Verge Of A Breakout?

GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…

Is Dick’s Sporting Goods Buying Foot Locker Smart?
Is Dick’s Sporting Goods Buying Foot Locker Smart?

Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…

Is Ginkgo Bioworks Stock a Good Buy?
Is Ginkgo Bioworks Stock a Good Buy?

Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
68
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
58
WIX alert for May 22

Wix.com [WIX] is up 2.11% over the past day.

Buy
81
DY alert for May 22

Dycom Industries [DY] is down 2.54% over the past day.

Sell
50
FICO alert for May 22

Fair Isaac [FICO] is up 3.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock